Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma.
Zhao J, Khong T, Gorniak M, Khaled A, McDonald Z, Reynolds J, Mithraprabhu S, Bingham N, Lim S, Wong D, Johnston A, Motorna O, Murphy N, Quach H, Yang L, Spencer A.
Zhao J, et al.
Haematologica. 2024 Nov 7. doi: 10.3324/haematol.2024.285933. Online ahead of print.
Haematologica. 2024.
PMID: 39506908
Free article.